JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lougheed, B.
Right arrow Articles by Withers, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lougheed, B.
Right arrow Articles by Withers, S. G.

J Biol Chem, Vol. 274, Issue 53, 37717-37722, December 31, 1999


Glycosyl Fluorides Can Function as Substrates for Nucleotide Phosphosugar-dependent Glycosyltransferases*

Brenda LougheedDagger , Hoa D. LyDagger , Warren W. Wakarchuk§, and Stephen G. WithersDagger

From the Dagger  Department of Chemistry, University of British Columbia, Vancouver, British Columbia V6T 1Z1 and the § Institute of Biological Sciences, National Research Council of Canada, Ottawa, Ontario K1A 0R6, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

alpha -Galactosyl fluoride is shown to function as a substrate, in place of uridine-5'-diphosphogalactose, for the alpha -galactosyltransferase from Neisseria meningitidis. The reaction only occurs in the presence of catalytic quantities of uridine 5'-diphosphate. In the presence of galactosyl acceptors, the expected oligosaccharide product is formed in essentially quantitative yields, reaction having been performed on multi-milligram scales. In the absence of a suitable acceptor, the enzyme synthesizes uridine-5'-diphosphogalactose, as demonstrated through a coupled assay in which uridine-5'-diphosphogalactose is converted to uridine-5'-diphosphoglucuronic acid with conversion of NAD to NADH. These glycosyl fluoride substrates therefore offer the potential of an inexpensive alternative donor substrate in the synthesis of oligosaccharides as well a means of generating steady state concentrations of nucleotide diphosphate sugars for in situ use by other enzymes. Further, they should prove valuable as mechanistic probes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Oligosaccharides, primarily in the form of various glycoconjugates, are involved in a wide variety of biological functions (1-3) and consequently show enormous potential as therapeutic agents for a number of conditions ranging from infectious diseases to cancer therapies (4-7). Their development as drugs, however, has been slow, in part because of difficulties with the large scale synthesis of oligosaccharides in an economic manner. Despite significant advances, chemical syntheses are generally impractical on the large scale since multiple protection and deprotection steps are typically required to control regiochemistry and because control of stereochemistry remains a challenge (8-10). Enzymatic synthesis provides an attractive alternative. The use of glycosidases run "backward" has a long history, but one which has been troubled by poor yields (11, 12), although the recent development of mutant glycosidases (glycosynthases) shows promise (13).

The alternative enzymatic approach involves the use of glycosyltransferases, nature's own anabolic enzymes, to form the very specific glycosyl linkages required (14, 15). Two problems have plagued this approach, one being the availability and stability of the enzymes, and the other being the cost of the nucleotide diphosphate sugar substrates. The former problem is being solved through the cloning and high level expression of the soluble catalytic domains, particularly of bacterial enzymes rather than their mammalian counterparts. The latter problem has been tackled through the development of complex, but effective recycling schemes to enzymatically regenerate the nucleotide diphosphate sugars (15). Although prices of nucleotide diphosphosugars are decreasing as recombinant strains producing them are developed, a problem still exists with end product (UDP) inhibition. A need therefore exists for detailed mechanistic information on these important enzymes, and for the development of alternative substrates that could prove more amenable to kinetic study and also less expensive for large scale synthesis. Such a system is described herein.

NDP1-sugar glycosyltransferases have been assigned to families on the basis of sequence similarities (16). They can also be classified mechanistically as either inverting or retaining, depending on the relative anomeric stereochemistries of their substrate and product, exactly as has been done with the well studied glycosidases (17, 18). This has led to the tacit assumption that similar mechanisms are followed by the two classes of enzyme. Mechanistic studies to date have been largely limited to kinetic analyses that reveal no common mechanism. Studies on the retaining glucosyltransferase glycogen synthase pointed to a rapid equilibrium random bi bi mechanism (19-21), while those on the inverting galactosyl (22) and fucosyl (23) transferases suggested rapid equilibrium random and ordered bi-bi schemes, respectively. Other studies have included measurement of positional isotope exchange and secondary deuterium kinetic isotope effects, as well as a few affinity labeling and photoaffinity labeling studies (see Ref. 17, and references therein). The only three-dimensional structures available to date are those of the phage T4 beta -glucosyltransferase, which unfortunately appears to be unrelated in amino acid sequence to any other enzyme (24) and very recently published structures of a bovine galactosyltransferase (25) and a presumed N-acetylglucosaminyltransferase from Bacillus subtilis (26).

Considerable effort has been expended in the probing of substrate specificities using modified donor and acceptor sugars (27-29). However, no functional substrate analogs have yet been reported in which the nucleotide diphosphate moiety is substantially altered or removed. Glycosyl fluorides have proven to be valuable substrates for glycosidases, both for use in synthesis and in probing mechanisms (30-35). The small size and high reactivity of the fluoride leaving group tends to ensure reasonable reaction rates with glycosidases, and the reaction can be easily monitored by use of a fluoride ion-selective electrode. It therefore seemed to be of value to test whether glycosyl fluorides could in fact function as alternate glycosyl donors for nucleotide diphosphate sugar-dependent glycosyltransferases. This could provide a much less expensive alternative for large scale syntheses as well as providing a simpler system for mechanistic studies.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

General Procedures-- Recombinant alpha -galactosyltransferase from Neisseria meningitidis lacking the 19 C-terminal amino acid residues was expressed in, and purified from, Escherichia coli as described previously (36). Concentrations of lgtC-19 solutions were determined based on epsilon 280 = 1.74 ml mg-1 cm-1 (36). Type II rabbit muscle pyruvate kinase and lactate dehydrogenase were obtained from Sigma as suspensions in 3.2 M ammonium sulfate, pH 6.0. UDP-galactose 4-epimerase from E. coli and UDP-glucose dehydrogenase from group A Streptococcus, were gifts from Dr. H. M. Holden (University of Wisconsin) and Dr. M. Tanner (University of British Columbia). respectively. alpha -Galactosyl fluoride was synthesized by reaction of penta-O-acetyl galactose with HF/pyridine, followed by deprotection using sodium methoxide in methanol as described previously (37, 38). Thin-layer chromatographic (TLC) separations were performed using Merck Kieselgel 60 F254 analytical plates. Compounds were detected visually (when possible) under long wavelength UV light, or by charring with either 5% sulfuric acid in methanol or 10% ammonium molybdate with 2 M sulfuric acid. Mass spectrometry was performed using a Sciex API 300 triple quadrupole LC/MS/MS electrospray mass spectrometer. NMR spectra were recorded on Varian Unity 500-MHz and Varian 300-MHz spectrometers. High pressure liquid chromatography (HPLC) was performed using a Waters HPLC system equipped with a Waters 410 differential refractometer on a Rainin DynamaxTM column (4.6 mm × 150 mm) equipped with a guard column (60 Å, 8-µm NH2-linked packing). Elution was performed with acetonitrile/water mixtures.

Enzymatic Synthesis-- Analytical runs were performed by adding 5 µl of 6 mg/ml lgtC-19 (0.9 nmol) to 3 µl of 115 mM alpha -galactosyl fluoride (0.35 µmol), 3 µl of 100 mM UDP (0.3 µmol), 5 µl of 5 mM acceptor (0.025 µmol), plus 4 µl of 500 mM HEPES buffer (pH 7.5) containing 50 mM MnCl2 and 25 mM DTT. Reaction progress was monitored by TLC using a solvent system of 7:2:1:0.1 ethyl acetate/methanol/H2O/acetic acid. Products were partially purified by loading onto a SepPak in deionized water, then eluting with 1:1 (v/v) acetonitrile/water.

Preparative scale synthesis was carried out by the addition of 15 µl of 1 M alpha -galactosyl fluoride (15 µmol), 5 µl of 1 M UDP (5 µmol), 100 µl of 500 mM Tris buffer (pH 7.5) containing 50 mM MnCl2 and 25 mM DTT to a vial. Approximately 78 nmol of purified lgtC-19 was added, followed by 40 µl of 250 mM lactose (10 µmol), and the vial incubated at room temperature. Progress was monitored by TLC. After 9 h, the pH had dropped to 5.0 and thus was adjusted to a pH of 7.5 by use of NaOH. After 23 h, the reaction had reached >90% completion (by TLC) and reaction was terminated by removal of the enzyme using an Amicon centrifugal concentrator (cut-off 10 kDa). Product was purified by HPLC, yielding 5 mg (9.9 µmol; 99%) of trisaccharide product. 1H NMR (D2O): (where A triple-bond  alpha -Gal(1,4), B triple-bond  beta -Gal(1,4), and C triple-bond  Glc) delta  5.22 (d, 0.4 H, J1, 2 = 3.6 Hz, H-1Calpha a), 4.95 (d, 1 H, J1, 2 = 3.6 Hz, H-1A), 4.66 (d, 0.6 H, J1, 2 = 8 Hz, H-1Cbeta b), 4.52 (d, 1 H, J1, 2 = 8 Hz, H-1B), 4.39 (t, 2 H, J5, 6 = 8 Hz, H-5A,B), 4.08 (t, 2 H, J4, 5 = J5, 6 = 3.6 Hz, H-4A,B), 3.6-4.0 (m, 12 H, H-2A,B,C; H-3A,B,C; H-4C; H-6A,B,C), 3.35 (t, 1 H, J5, 6 = 8 Hz, H-5C).

Kinetic Analysis-- Kinetic parameters for the transfer of galactose from alpha -galactosyl fluoride to lactose by lgtC-19 were determined using a continuous assay in which fluoride release was monitored. For standard assays, a solution containing 100 mM HEPES (pH 7.5 or 7.0), 2.5 mM MnCl2, 5 mM DTT, and 2 mM UDP plus appropriate concentrations of lactose and alpha -galactosyl fluoride was incubated at 30 °C. The spontaneous hydrolysis of alpha -galactosyl fluoride was monitored for 5 min before lgtC-19 was added to initiate the transfer reaction, giving a final assay volume of 300 µl. The reaction was then followed for 10 min and the reaction rate corrected for the background hydrolysis.

The continuous coupled assay monitoring UDP-Gal production was carried out in assay cells containing 100 mM HEPES (pH 7.5), 15 mM MnCl2, 0.5 mM UDP, 5 mM DTT, 0.5 mM NAD+, 4.3 mg/ml UDP-galactose 4-epimerase, and 1.03 mg/ml UDP-glucose dehydrogenase plus alpha -galactosyl fluoride (0-200 mM) in a total volume of 190 µl. Reactions were initiated by the addition of lgtC-19 (3.07 nmol), bringing the final volume to 200 µl, and monitored through the change in absorbance at a wavelength of 340 nm (epsilon 340 = 6.22 mM-1 cm-1). Control experiments were performed to confirm that UDP-glucuronic acid did not inhibit the coupling system significantly at the concentrations formed during initial rate analysis. Similarly, control experiments in which lgtC-19 was omitted confirmed that alpha -galactosyl fluoride plus UDP could not function as substrates for UDP-galactose-4-epimerase and UDP-glucose dehydrogenase. Subsequent investigations revealed that the substrate specificity of the dehydrogenase is sufficiently broad that the epimerase is not needed.

Competitive rate reduction upon addition of lactose was measured by incubating cells as above, but containing a fixed concentration (50 mM) of alpha -galactosyl fluoride and varying the concentration of lactose over a range of 0-120 mM.

Mathematical Treatment of Data-- All kinetic parameters were determined by direct fit of the data using the software program Grafit (39). Derivation and manipulation of Equations 1 and 2 was performed using the method of King-Altman (40) and the software program Mathematica (41). Due to the complexity of Equation 3, its derivation and manipulation was performed solely using Mathematica.

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

alpha -Galactosyl fluoride was first tested as a donor substrate for the recombinant lipopolysaccharide galactosyltransferase C (lgtC-19) from N. meningitidis (36) in the presence of several readily-detected fluorescent galactosides as acceptors. When reaction mixtures containing alpha -galactosyl fluoride plus, individually, FITC lac, FCHASE gal, and FCHASE lac were incubated with lgtC-19 in buffer containing Mn2+ and DTT, no reaction product could be detected after 1 h by thin-layer chromatography or HPLC analysis, or by use of a fluoride electrode. However, when uridine 5'-diphosphate (UDP) was also added, complete conversion of the fluorescent galactoside to a disaccharide and of the fluorescent lactosides to the corresponding trisaccharides was observed within that same time frame. Neither UMP nor UTP functioned equivalently. The products observed were chromatographically identical to that formed using UDP-Gal as glycosyl donor. Further, mass spectrometric analysis of the Sep-Pak-purified products confirmed the expected masses of 905.4 for FCHASE-gal-gal, 1067.6 for FCHASE-lac-gal, and 985.2 for FITC-lac-gal. Repeat of the reaction on a larger scale but using lactose as the acceptor allowed the production and HPLC purification of multi-milligram quantities of pure product. 1H NMR analysis confirmed that this product was indeed a trisaccharide, as evidenced by the presence of two anomeric proton resonances from sugars involved in glycosidic linkages at delta  4.95 ppm (J = 3.6 Hz), 4.52 ppm (J = 8 Hz) and the two resonances due to the alpha - and beta - protons of the reducing end hemiacetal at delta  5.22 ppm (J = 3.6 Hz) and 4.66 ppm (J = 8 Hz). The formation of a Gal alpha 1,4-Gal linkage in the structure Gal alpha 1,4-Gal beta 1,4-Glc is confirmed by the resonance at delta  4.95 ppm. This chemical shift is essentially identical to that of delta  4.96 ppm measured previously for this same linkage in an oligosaccharide containing the fragment Gal alpha 1,4-Gal beta 1,4-Glc alpha 1,2- (42). Further, a strong NOE was observed between this resonance and that at delta  4.05 ppm assigned to H-4 of the Gal beta 1,4-Glc.

Through the use of a fluoride-sensitive electrode, the initial rate of fluoride release from alpha -galactosyl fluoride (in the presence of 2 mM UDP and 65 or 100 mM acceptor substrate, lactose) was monitored and kinetic parameters were determined. At low concentrations of alpha -galactosyl fluoride, a linear dependence of rate upon alpha -galactosyl fluoride concentration was observed (Fig. 1a), allowing the determination of the second order rate constant to be kcat/Km = 1 × 10-4 mM-1 s-1. However, as the concentration of alpha -galactosyl fluoride was increased, no saturation behavior was observed. Instead, a distinct upward curvature in the plot of rate as a function of alpha -galactosyl fluoride concentration was seen (Fig. 1b). This result suggests that, at sufficiently high concentrations, a second molecule of alpha -galactosyl fluoride can become involved in the reaction leading to an increase in the observed rates. Since the acceptor for this enzyme is a galactosyl moiety, it is likely that this second molecule of alpha -galactosyl fluoride is functioning as an alternative acceptor, giving alpha -Gal-1,4-alpha -GalF as the product. The formation of this product has indeed been confirmed by TLC and HPLC analysis of a reaction mixture containing UDP, alpha -galactosyl fluoride, and enzyme. In addition, the enzyme was also shown to be capable of reaction when assayed with only alpha -galactosyl fluoride and UDP, in the absence of other glycosyl acceptors (Fig. 2). The second order rate constant for this transfer of galactose from alpha -galactosyl fluoride to a second molecule of alpha -galactosyl fluoride was determined to be 2 × 10-4 mM-1 s-1.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Rate of galactosyl transfer to lactose at low (a) and high (b) concentrations of the donor substrate, alpha -galactosyl fluoride. Equations 1-3 all yielded the same fit to the data in b.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Rate of galactosyl transfer in the presence of only UDP and alpha -galactosyl fluoride.

The dual role of alpha -galactosyl fluoride in the presence of another glycosyl acceptor such as lactose can be described kinetically by three possible models, depending on whether substrate binding proceeds via a ping pong, ordered, or random mechanism (Scheme 1, a-c, respectively). The simplified initial velocity equation for each of these mechanisms is given below. The individual rate constants comprising each constant term in these equations are summarized in Table I.
&ngr;=<FR><NU>V<SUB>1</SUB>[B][A]+V<SUB>2</SUB>[A]<SUP>2</SUP></NU><DE>(K<SUB>1</SUB>[B])+(K<SUB>2</SUB>+[B])[A]+K<SUB>3</SUB>[A]<SUP>2</SUP></DE></FR> (Eq. 1)

&ngr;=<FR><NU>V<SUB>1</SUB>[B][A]+V<SUB>2</SUB>[A]<SUP>2</SUP></NU><DE>(K<SUB>1</SUB>+K<SUB>2</SUB>[B])+(K<SUB>3</SUB>+[B])[A]+K<SUB>4</SUB>[A]<SUP>2</SUP></DE></FR> (Eq. 2)

&ngr;=<FR><NU>(V<SUB>1</SUB>[B]<SUP>2</SUP>+V<SUB>2</SUB>[B])[A]+(V<SUB>3</SUB>+V<SUB>4</SUB>[B])[A]<SUP>2</SUP>+V<SUB>5</SUB>[A]<SUP>3</SUP></NU><DE>(K<SUB>1</SUB>+K<SUB>2</SUB>[B]+K<SUB>3</SUB>[B]<SUP>2</SUP>)+(K<SUB>4</SUB>+[B]+K<SUB>5</SUB>[B]<SUP>2</SUP>)[A]+(K<SUB>6</SUB>+K<SUB>7</SUB>[B])[A]<SUP>2</SUP>+K<SUB>8</SUB>[A]<SUP>3</SUP></DE></FR> (Eq. 3)
At a fixed concentration of lactose, the rate equations in terms of alpha -galactosyl fluoride concentration have the same general form for both ping pong (Equation 1) and ordered (Equation 2) mechanisms. On the other hand, the rate equation describing the random mechanism (Equation 3) is quite different. Nonetheless, the fact that the data in Fig. 1b can be fitted equally well by each equation demonstrates that it is possible for alpha -galactosyl fluoride to behave as both donor and alternate acceptor substrates regardless of the kinetic mechanism employed for substrate binding. Differentiation between these mechanisms will require measurements of rates at a series of concentrations of alpha -galactosyl fluoride, UDP, and lactose, as well as product inhibition studies.


View larger version (14K):
[in this window]
[in a new window]
 
Scheme 1.   Possible kinetic mechanisms of lgtC-19 describing the dual role of alpha -galactosyl fluoride as both donor and acceptor substrate in the presence of a second glycosyl acceptor. a, ping pong; b, ordered; c, random. E, UDP-bound enzyme; F, covalent galactosyl enzyme; A, alpha -galactosyl fluoride; B, lactose; P, fluoride; Q, trisaccharide (alpha -Gal-1,4-beta -Gal-1,4-Glc); Q', disaccharide (alpha -Gal-1,4-alpha -GalF).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of rate constants and enzyme concentration terms comprising the constant terms in Equations 1-3

The complicated nature of alpha -galactosyl fluoride functioning in the capacity of both donor and acceptor substrate has made it difficult to determine individual values of kcat and Km for alpha -galactosyl fluoride and lactose in the galactosylation reaction. An estimate of the enzyme's affinity for UDP was obtained by measuring rates at fixed concentrations of alpha -galactosyl fluoride (100 mM) and lactose (100 mM) while varying UDP concentration. Here, saturation kinetics were observed (Fig. 3) and an apparent Km value of 0.08 mM was obtained.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   A plot demonstrating the saturating behavior of UDP at high concentrations.

The absolute requirement for UDP is of interest, but not entirely unexpected, since UDP is probably required to optimally orient residues for catalysis. The small size of the fluorine substituent on the galactose moiety must allow for both alpha -galactosyl fluoride and UDP to bind coincidentally in the donor site. By analogy with retaining glycosidases, an intermediate of some kind is presumably formed, which then reacts with a glycosyl acceptor (Scheme 2, upper pathway). This intermediate is shown here as a covalent glycosyl-enzyme, but may well take any form. It is conceivable that such an intermediate could also react with UDP to form UDP-Gal (Scheme 2, lower pathway). However, the detection of UDP-Gal formation is a challenging endeavor given that UDP-Gal binds tightly to the enzyme (Km = 30 µM) and will cause severe product inhibition. As a consequence, no significant accumulation of UDP-Gal will occur. In addition, any UDP-Gal formed can be turned over by the enzyme in the galactosylation of alpha -galactosyl fluoride, which can function as an acceptor substrate. To circumvent this problem, a coupled assay was developed to partition off any UDP-Gal formed, thereby allowing for its detection and quantitation (Scheme 2). In this assay, the enzyme UDP-Gal 4-epimerase was used to convert any UDP-Gal formed by the transferase to UDP-Glc. The latter was then oxidized by a second enzyme UDP-Glc dehydrogenase to UDP-glucuronic acid with concomitant reduction of NAD+ to NADH.


View larger version (19K):
[in this window]
[in a new window]
 
Scheme 2.   lgtC-19 catalyzed formation of lactose or UDP-Gal from alpha -galactosyl fluoride. R, alpha -F or beta -1,4-Glc; U, uracil; P, phosphate; 1, alpha -galactosyltransferase; 2, UDP-Gal epimerase; 3, UDP-Glc dehydrogenase.

As shown in Fig. 4a, a rate that was dependent upon the concentration of alpha -galactosyl fluoride was indeed observed. Once again, the absence of any saturation is consistent with a low affinity of the transferase for alpha -galactosyl fluoride. From the linear dependence of the data, the kcat/Km value was determined to be 7 × 10-5 mM-1 s-1. The reasonable agreement of this value with that obtained for the galactosylation of alpha -galactosyl fluoride in the absence of another glycosyl acceptor (2 × 10-4 mM-1 s-1) is consistent with the notion that the same step, formation of the intermediate, is rate-limiting in both cases. Furthermore, the introduction of lactose also resulted in the suppression of UDP-Gal production, as can be seen in the decreased rates at increasing concentrations of this additional acceptor (Fig. 4b). This is not surprising, as the presence of a second glycosyl acceptor would cause a greater partitioning of the intermediate toward the synthesis of oligosaccharides instead of UDP-Gal. The saturable dependence of this rate decrease as a function of lactose concentration allowed the determination of an apparent Km value of 7 mM for lactose under these conditions (50 mM alpha -galactosyl fluoride, 0.5 mM UDP).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 4.   UDP-Gal formation as measured by the coupled assay. a, rate of UDP-Gal formation as a function of alpha -galactosyl fluoride concentration. Data have been corrected for the small background absorbance change seen in the absence of alpha -galactosyl fluoride. b, decrease in the rate of UDP-Gal formation upon addition of lactose.

The ability of glycosyl fluorides to act as substrates for NDP-sugar-dependent glycosyltransferases carries two major implications. One is that these retaining transferases are likely mechanistically analogous to retaining glycosidases and proceed through some kind of glycosyl-enzyme intermediate. They may therefore be amenable to study using many of the mechanistic tools developed for glycosidases. The other is that such glycosyl fluorides could serve as inexpensive alternatives to NDP-sugars in the synthesis of oligosaccharides, the nucleotide diphosphate being needed only in catalytic quantities. The system could also serve as a means of generating UDP-sugars in situ for use by other enzymes. The rather low kcat/Km value is not as serious a problem as might appear to be the case, being due mostly to a high Km value for alpha -galactosyl fluoride, which can be overcome through the use of high substrate concentrations. As shown in the preparative synthesis, the use of high concentrations of both the donor and acceptor resulted in good product yields with no significant quantities of side products.

    ACKNOWLEDGEMENTS

We thank Dr. Hazel Holden and Dr. Martin Tanner for generous gifts of UDP-Gal epimerase and UDP-glucose dehydrogenase, respectively. In addition, we extend our gratitude to Melissa J. Schur and Dr. Manuela Dieckelmann for their help in the preparation of the enzyme.

    FOOTNOTES

* This work was supported by the Natural Sciences and Engineering Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 604-822-3402; Fax: 604-822-2847; E-mail: withers@chem.ubc.ca.

    ABBREVIATIONS

The abbreviations used are: NDP, nucleotide diphosphate; FCHASE, 6-(5-fluoresceincarboxamido)-hexanoic acid succinimidyl; FITC, fluorescein isothiocyanate; lgtC-19, lipopolysaccharide galactosyltransferase C from N. meningitidis missing the 19 C-terminal amino acid residues; DTT, dithiothreitol; HPLC, high performance liquid chromatography.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

1. Varki, A. (1993) Glycobiology 3, 97[Abstract/Free Full Text]
2. Kobata, A. (1993) Acc. Chem. Res. 26, 319[CrossRef]
3. Dwek, R. A. (1996) Chem. Rev. 96, 683-720[CrossRef][Medline] [Order article via Infotrieve]
4. Sears, P., and Wong, C. H. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12086-12093[Abstract/Free Full Text]
5. Simon, P. M. (1996) Drug Disc. Today 1, 522-528[CrossRef]
6. Wong, C. H., Halcomb, R. L., Ichikawa, Y., and Kajimoto, T. (1995) Angew. Chem. Int. Ed. Engl. 34, 521-546[CrossRef]
7. Zopf, D., and Roth, S. (1996) Lancet 347, 1017-1021[CrossRef][Medline] [Order article via Infotrieve]
8. Douglas, S. P., Whitfield, D. M., and Krepinsky, J. J. (1991) J. Am. Chem. Soc. 113, 5095[CrossRef]
9. Boons, G. J. (1996) Tetrahedron 52, 1095-1121[CrossRef]
10. Danishefsky, S. J., and Bilodeau, M. T. (1996) Angew. Chem. Int. Ed. Engl. 35, 1380-1419[CrossRef]
11. Nilsson, K. G. I. (1988) Trends Biotechnol. 6, 256-264[CrossRef]
12. Thiem, J. (1995) FEMS Microbiol. Rev. 16, 193-211[CrossRef][Medline] [Order article via Infotrieve]
13. Mackenzie, L. F., Wang, Q., Warren, R. A. J., and Withers, S. G. (1998) J. Am. Chem. Soc. 120, 5583-5584[CrossRef]
14. Beyer, T. A., Sadler, E., Rearick, J. I., Paulson, J. C., and Hill, R. L. (1982) Adv. Enzymol. Relat. Areas Mol. Biol. 52, 23-175
15. Ichikawa, Y., Lin, Y. C., Dumas, D. P., Shen, G. J., Garcia-Junceda, E., Williams, M. A., Bayer, R., Ketcham, C., Walker, L. E., Paulson, J. C., and Wong, C. H. (1992) J. Am. Chem. Soc. 114, 9283-9298[CrossRef]
16. Campbell, J. A., Davies, G. J., Bulone, V., and Henrissat, B. (1997) Biochem. J. 326, 929-942
17. Davies, G., Withers, S. G., and Sinnott, M. L. (1997) in Comprehensive Biological Catalysis (Sinnott, M. L., ed), Vol. 1 , pp. 119-208, Academic Press, London
18. Sinnott, M. L. (1990) Chem. Rev. 90, 1171-1202[CrossRef]
19. Gold, A. M. (1980) Biochemistry 19, 3766-3772[CrossRef][Medline] [Order article via Infotrieve]
20. Salsas, E., and Larner, J. (1975) J. Biol. Chem. 250, 3471-3475[Abstract/Free Full Text]
21. Plesner, L., Plesner, I. W., and Esmann, V. (1974) J. Biol. Chem. 249, 1119-1125[Abstract/Free Full Text]
22. Bell, J. E., Beyer, T. A., and Hill, R. L. (1976) J. Biol. Chem. 251, 3003-3013[Abstract/Free Full Text]
23. Qiao, L., Murray, B. W., Shimazaki, M., Schultz, J., and Wong, C. H. (1996) J. Am. Chem. Soc. 118, 7653-7662[CrossRef]
24. Vrielink, A., Ruger, W., Driessen, H. P. C., and Freemont, P. S. (1994) EMBO J. 13, 3413-3422[Medline] [Order article via Infotrieve]
25. Gastinel, L. N., Cambillau, C., and Bourne, Y. (1999) EMBO J. 18, 3546-3557[CrossRef][Medline] [Order article via Infotrieve]
26. Charnock, S. J., and Davies, G. J. (1999) Biochemistry 38, 6380-6385[CrossRef][Medline] [Order article via Infotrieve]
27. Palcic, M. M., and Hindsgaul, O. (1991) Glycobiology 1, 205-209[Abstract/Free Full Text]
28. Lowary, T. L., and Hindsgaul, O. (1993) Carbohydr. Res. 249, 163-195[CrossRef][Medline] [Order article via Infotrieve]
29. Lowary, T. L., and Hindsgaul, O. (1994) Carbohydr. Res. 251, 33-67[CrossRef][Medline] [Order article via Infotrieve]
30. Kobayashi, S., Kashiwa, K., Kawasaki, T., and Shoda, S. I. (1991) J. Am. Chem. Soc. 113, 3079-3084[CrossRef]
31. Hehre, E. J., Matsui, H., and Brewer, C. F. (1990) Carbohydr. Res. 198, 123-132[CrossRef][Medline] [Order article via Infotrieve]
32. Konstantinidis, A. K., Marsden, I., and Sinnott, M. L. (1993) Biochem. J. 291, 833-838
33. Lindhorst, T. K., Braun, C., and Withers, S. G. (1995) Carbohydr. Res. 268, 93-106[CrossRef]
34. Moreau, V., and Driguez, H. (1996) J. Chem. Soc. Perkin Trans. 21, 525-527
35. Sierks, M. R., and Svensson, B. (1996) Biochemistry 35, 1865-1871[CrossRef][Medline] [Order article via Infotrieve]
36. Wakarchuk, W. W., Cunningham, A., Watson, D. C., and Young, N. M. (1998) Protein Eng. 11, 295-302[Abstract/Free Full Text]
37. Hayashi, M., Hashimoto, S., and Noyori, R. (1984) Chem. Lett. 1747-1750
38. Zemplen, G., and Pacsu, E. (1929) Chem. Ber. 62, 1613-7
39. Leatherbarrow, R. J. (1990) Grafit, version 3.0 , Erithacus Software Ltd., Staines, United Kingdom
40. King, E. L., and Altman, C. (1956) J. Phys. Chem. 60, 1375[CrossRef]
41. Wolfram, S. (1996) Mathematica, version 3.0 , Wolfram Research Inc., Champaign, IL
42. Edebrink, P., Jansson, P. E., Widmalm, G., Holmè, T., and Rahman, M. (1996) Carbohydr. Res. 295, 127-146[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. D. Leipold, N. A. Kaniuk, and C. Whitfield
The C-terminal Domain of the Escherichia coli WaaJ Glycosyltransferase Is Important for Catalytic Activity and Membrane Association
J. Biol. Chem., January 12, 2007; 282(2): 1257 - 1264.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. M. Logan, E. Altman, O. Mykytczuk, J.-R. Brisson, V. Chandan, F. St. Michael, A. Masson, S. Leclerc, K. Hiratsuka, N. Smirnova, et al.
Novel biosynthetic functions of lipopolysaccharide rfaJ homologs from Helicobacter pylori
Glycobiology, July 1, 2005; 15(7): 721 - 733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chen, Z. Liu, J. Wang, J. Fang, H. Fan, and P. G. Wang
Changing the Donor Cofactor of Bovine alpha 1,3-Galactosyltransferase by Fusion with UDP-galactose 4-Epimerase. MORE EFFICIENT BIOCATALYSIS FOR SYNTHESIS OF alpha -Gal EPITOPES
J. Biol. Chem., October 6, 2000; 275(41): 31594 - 31600.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lougheed, B.
Right arrow Articles by Withers, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lougheed, B.
Right arrow Articles by Withers, S. G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.